Navigating Neonatal Abstinence Syndrome for NICU Leaders
This presentation discusses contemporary issues surrounding the assessment and management of neonatal abstinence syndrome and the challenges faced by NICU nursing leaders.
- Describe the current trends in the incidence of NAS in the US and at least one effect this trend has on the healthcare system and/or on NICU’s.
- Outline two or more challenges frequently encountered when using clinical assessment tools for infants with NAS, and two recent innovations.
- List three pharmacologic and/or non-pharmacologic treatment options for infants with NAS.
- Discuss two reasons why understanding local data prior to implementing process change is critical for a program’s success
Stephen DeMeo, DO, MEd
Dr. Stephen DeMeo is a Neonatologist at WakeMed in Raleigh, NC, and a Regional Assistant Dean for the Campbell University School of Medicine. He completed his fellowship in Neonatal-Perinatal Medicine at Duke University Medical Center, and his internship/residency in Pediatrics at the Jefferson/Alfred I. duPont Hospital for Children in Wilmington, DE, serving as Chief Resident. Outside of the hospital, he serves on the executive board of the North Carolina March of Dimes, and is a founding board member of Books That Heal, a non-profit that engages with children facing severe illness, to write and publish their own books.